Literature DB >> 9756538

Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle.

C H Fang1, B G Li, J J Wang, J E Fischer, P O Hasselgren.   

Abstract

Thermal injury is associated with a pronounced catabolic response in skeletal muscle, reflecting inhibited protein synthesis and increased protein breakdown, in particular myofibrillar protein breakdown. Administration of insulin-like growth factor I (IGF-I) has a nitrogen-sparing effect after burn injury, but the influence of this treatment on protein turnover rates in skeletal muscle is not known. In the present study, we examined the effect of IGF-I on muscle protein synthesis and breakdown rates following burn injury in rats. After a 30% total body surface area burn injury or sham procedure, rats were treated with a continuous infusion of IGF-I (3. 5 or 7 mg . kg-1 . 24 h-1) for 24 h. Protein synthesis and breakdown rates were determined in incubated extensor digitorum longus muscles. Burn injury resulted in increased total and myofibrillar protein breakdown rates and reduced protein synthesis in muscle. The increase in protein breakdown rates was blocked by both doses of IGF-I and the burn-induced inhibition of muscle protein synthesis was partially reversed by the higher dose of the hormone. IGF-I did not influence muscle protein turnover rates in nonburned rats. The results suggest that the catabolic response to burn injury in skeletal muscle can be inhibited by IGF-I.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756538     DOI: 10.1152/ajpregu.1998.275.4.R1091

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.

Authors:  Paul Gregorevic; David R Plant; Kerri S Leeding; Leon A Bach; Gordon S Lynch
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Thermal injury activates the eEF2K-dependent eEF2 pathway in pediatric patients.

Authors:  Juquan Song; Celeste C Finnerty; David N Herndon; Robert Kraft; Darren Boehning; Natasha C Brooks; Ronald G Tompkins; Marc G Jeschke
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-01-23       Impact factor: 4.016

3.  Constitutive activation of CaMKKα signaling is sufficient but not necessary for mTORC1 activation and growth in mouse skeletal muscle.

Authors:  Jeremie L A Ferey; Jeffrey J Brault; Cheryl A S Smith; Carol A Witczak
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

4.  Insulin effects on glucose tolerance, hypermetabolic response, and circadian-metabolic protein expression in a rat burn and disuse model.

Authors:  Heather F Pidcoke; Lisa A Baer; Xiaowu Wu; Steven E Wolf; James K Aden; Charles E Wade
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-23       Impact factor: 3.619

5.  Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation.

Authors:  O Schakman; M Dehoux; S Bouchuari; S Delaere; P Lause; N Decroly; S E Shoelson; J-P Thissen
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-26       Impact factor: 4.310

6.  The Systemic Effect of Burn Injury and Trauma on Muscle and Bone Mass and Composition.

Authors:  Jacob Rinkinen; Charles D Hwang; Shailesh Agarwal; Eboda Oluwatobi; Jonathan Peterson; Shawn Loder; Robert C Brownly; Timothy Cummings; Paul S Cederna; Benjamin Levi
Journal:  Plast Reconstr Surg       Date:  2015-11       Impact factor: 4.730

Review 7.  Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche.

Authors:  T Ollewagen; K H Myburgh; M van de Vyver; C Smith
Journal:  J Biomed Sci       Date:  2021-03-03       Impact factor: 8.410

8.  Supplementation of carnitine leads to an activation of the IGF-1/PI3K/Akt signalling pathway and down regulates the E3 ligase MuRF1 in skeletal muscle of rats.

Authors:  Janine Keller; Aline Couturier; Melanie Haferkamp; Erika Most; Klaus Eder
Journal:  Nutr Metab (Lond)       Date:  2013-03-15       Impact factor: 4.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.